Mangosteen xanthones suppress hepatitis C virus genome replication

Choi, Moonju; Kim, Young-Mi; Lee, Sungjin; Chin, Young-Won; Lee, Choongho
October 2014
Virus Genes;Oct2014, Vol. 49 Issue 2, p208
Academic Journal
Hepatitis C virus (HCV) is a hepatotropic single-stranded RNA virus. HCV infection is causally linked with development of liver cirrhosis and hepatocellular carcinoma. Enhanced production of reactive oxygen species by HCV has been implicated to play an important role in HCV-induced pathogenesis. Mangosteen has been widely used as a traditional medicine as well as a dietary supplement ,thanks to its powerful anti-oxidant effect. In the present study, we demonstrated that the ethanol extract from mangosteen fruit peels (MG-EtOH) is able to block HCV genome replication using HCV genotype 1b Bart79I subgenomic (EC 5.1 μg/mL) and genotype 2a J6/JFH-1 infectious replicon systems (EC 3.8 μg/mL). We found that inhibition of HCV replication by MG-EtOH led to subsequent down-regulation of expression of HCV proteins. Interestingly, MG-EtOH exhibited a modest inhibitory effect on in vitro RNA polymerase activity of NS5B. Among a number of xanthones compounds identified within this MG-EtOH, we discovered α-MG (EC 6.3 μM) and γ-MG (EC 2.7 μM) as two major single molecules responsible for suppression of HCV replication. This finding will provide a valuable molecular basis to further develop mangosteen as an important dietary supplement to combat HCV-induced liver diseases.


Related Articles

  • Small tRNA-derived RNAs are increased and more abundant than microRNAs in chronic hepatitis B and C. Selitsky, Sara R.; Baran-Gale, Jeanette; Honda, Masao; Yamane, Daisuke; Masaki, Takahiro; Fannin, Emily E.; Guerra, Bernadette; Shirasaki, Takayoshi; Shimakami, Tetsuro; Kaneko, Shuichi; Lanford, Robert E.; Lemon, Stanley M.; Sethupathy, Praveen // Scientific Reports;1/9/2015, p7675 

    Persistent infections with hepatitis B virus (HBV) or hepatitis C virus (HCV) account for the majority of cases of hepatic cirrhosis and hepatocellular carcinoma (HCC) worldwide. Small, non-coding RNAs play important roles in virus-host interactions. We used high throughput sequencing to conduct...

  • Hepatitis C virus strategies to evade the specific-T cell response: a possible mission favoring its persistence. Quarleri, Jorge Fabián; Oubiña, José Raúl // Annals of Hepatology: Official Journal of the Mexican Associatio;Jan/Feb2016, Vol. 15 Issue 1, p17 

    Hepatitis C virus (HCV) is a small, enveloped RNA virus. The number of HCV-infected individuals worldwide is estimated to be approximately 200 million. The vast majority of HCV infections persist, with up to 80% of all cases leading to chronic hepatitis associated with liver fibrosis, cirrhosis,...

  • Different expression systems for production of HCV structural proteins. Mirnurollahi, Masoumeh; Irani, Shiva; Bolhassani, Azam // Journal of Paramedical Sciences;Autumn2015, Vol. 6 Issue 4, p15 

    Hepatitis C virus (HCV) is an important agent causing chronic liver infection, which often leads to liver cirrhosis and lethal hepatocellular carcinoma (HCC). At present, there is no effective HCV vaccine for prevention of hepatic disease and the standard treatment is neither economical nor...

  • PPARs and HCV-Related Hepatocarcinoma: A Mitochondrial Point of View. Agriesti, Francesca; Tataranni, Tiziana; Ruggieri, Vitalba; Capitanio, Nazzareno; Piccoli, Claudia // PPAR Research;2012, Special section p1 

    Hepatitis-C-virus-related infective diseases are worldwide spread pathologies affecting primarily liver. The infection is often asymptomatic, but when chronically persisting can lead to liver scarring and ultimately to cirrhosis, which is generally apparent after decades. In some cases,...

  • Hepatitis C Virus Life Cycle and Lipid Metabolism. Popescu, Costin-Ioan; Riva, Laura; Vlaicu, Ovidiu; Farhat, Rayan; Rouillé, Yves; Dubuisson, Jean // Biology (2079-7737);2014, Vol. 3 Issue 4, p892 

    Hepatitis C Virus (HCV) infects over 150 million people worldwide. In most cases HCV infection becomes chronic, causing liver disease ranging from fibrosis to cirrhosis and hepatocellular carcinoma. HCV affects the cholesterol homeostasis and at the molecular level, every step of the virus life...

  • Evidence for Novel Hepaciviruses in Rodents. Drexler, Jan Felix; Corman, Victor Max; Müller, Marcel Alexander; Lukashev, Alexander N.; Gmyl, Anatoly; Coutard, Bruno; Adam, Alexander; Ritz, Daniel; Leijten, Lonneke M.; van Riel, Debby; Kallies, Rene; Klose, Stefan M.; Gloza-Rausch, Florian; Binger, Tabea; Annan, Augustina; Adu-Sarkodie, Yaw; Oppong, Samuel; Bourgarel, Mathieu; Rupp, Daniel; Hoffmann, Bernd // PLoS Pathogens;Jun2013, Vol. 9 Issue 6, p1 

    Hepatitis C virus (HCV) is among the most relevant causes of liver cirrhosis and hepatocellular carcinoma. Research is complicated by a lack of accessible small animal models. The systematic investigation of viruses of small mammals could guide efforts to establish such models, while providing...

  • Improving treatment not enough to reduce liver disease burden. Schlansky, Barry // Clinician Reviews;Nov2015, Vol. 25 Issue 11, p49 

    The article discusses findings of a study which forecasted decline in the prevalence of cirrhosis in 2021 and continued surge in hepatitis C virus (HCV).

  • CD8+ T-cell responses in acute hepatitis C virus infection. Pil Soo Sung; Racanelli, Vito; Eui-Cheol Shin // Frontiers in Immunology;Jun2014, Vol. 5, p1 

    Hepatitis C virus (HCV) infects approximately 170 million people worldwide and is a major cause of life-threatening liver diseases such as liver cirrhosis and hepatocellular carcinoma. Acute HCV infection often progresses to chronic persistent infection, although some patients recover...

  • Abnormalities identified in the liver after HCV eradication.  // Hem/Onc Today;12/10/2011, Vol. 12 Issue 23, p31 

    The article reports on the findings of a study by N. Aizawa and colleagues which showed the identification of histological abnormalities in noncancerous hepatic tissues of hepatocellular carcinoma patients following hepatitis C virus eradication, presented at the American Association for the...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics